top of page
O nás: Who We Are
mMEDCON logo (1).png

Do you know that....
Approximately 1 in 40 people are carriers of the genetic mutation that causes SMA, making it one of the most common genetic disorders.

In the MENA region, the lack of standardized referral pathways for Duchenne Muscular Dystrophy (DMD) causes delays in diagnosis and treatment. We aim to build AI-driven software to analyze low MRI muscle tissue scan to provide early detection and comprehensive evaluation of disease management.

OUR MAIN PROJECTS INCLUDE:

medical problem solving contest and summer academy focused on clinical practice

journalism for young scientists with a focus on research

weekend workshops 

*European Commission, report on Slovakia 2020

Screenshot 2024-07-09 134341.png

Our
Mission &
Impact

AI powered muscle analytics

simple to use for clinicians

easy access for patients

early and reliable diagnosis

IMG_1119_edited.jpg

Terezia Jurasova

Founder of MyoMetricsMRI

1.png

Call 

+421 902 950 910

Email 

Follow

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
bottom of page